Source: Annual Congress 2013 –Is it really asthma?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Mironova, V. Trofimov, M. Dubina, V. Belash, A. Ulitina (Saint-Petersburg, Russian Federation). Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population. Eur Respir J 2013; 42: Suppl. 57, 359

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Overlap phenotypes of asthma in adults: Obesity and atopy Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Usefulness of periostin as a biomarker of pediatric asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Refined severity assessment of asthmatic children using molecular allergy diagnostics Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 The clinical and genetic factors for predicting the response to inhaled corticosteroids Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Genetic polymorphisms in early and late-onset bronchial asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW) Source: International Congress 2014 – More paediatric asthma Year: 2014 Study of the correlations between FENO and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Novel asthma definition for epidemiological studies Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013